Cargando…
The developing story of Sprouty and cancer
Sprouty proteins are evolutionarily conserved modulators of MAPK/ERK pathway. Through interacting with an increasing number of effectors, mediators, and regulators with ultimate influence on multiple targets within or beyond ERK, Sprouty orchestrates a complex, multilayered regulatory system and med...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113681/ https://www.ncbi.nlm.nih.gov/pubmed/24744103 http://dx.doi.org/10.1007/s10555-014-9497-1 |
_version_ | 1782328320837287936 |
---|---|
author | Masoumi-Moghaddam, Samar Amini, Afshin Morris, David Lawson |
author_facet | Masoumi-Moghaddam, Samar Amini, Afshin Morris, David Lawson |
author_sort | Masoumi-Moghaddam, Samar |
collection | PubMed |
description | Sprouty proteins are evolutionarily conserved modulators of MAPK/ERK pathway. Through interacting with an increasing number of effectors, mediators, and regulators with ultimate influence on multiple targets within or beyond ERK, Sprouty orchestrates a complex, multilayered regulatory system and mediates a crosstalk among different signaling pathways for a coordinated cellular response. As such, Sprouty has been implicated in various developmental and physiological processes. Evidence shows that ERK is aberrantly activated in malignant conditions. Accordingly, Sprouty deregulation has been reported in different cancer types and shown to impact cancer development, progression, and metastasis. In this article, we have tried to provide an overview of the current knowledge about the Sprouty physiology and its regulatory functions in health, as well as an updated review of the Sprouty status in cancer. Putative implications of Sprouty in cancer biology, their clinical relevance, and their proposed applications are also revisited. As a developing story, however, role of Sprouty in cancer remains to be further elucidated. |
format | Online Article Text |
id | pubmed-4113681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-41136812014-07-30 The developing story of Sprouty and cancer Masoumi-Moghaddam, Samar Amini, Afshin Morris, David Lawson Cancer Metastasis Rev Non-Thematic Review Sprouty proteins are evolutionarily conserved modulators of MAPK/ERK pathway. Through interacting with an increasing number of effectors, mediators, and regulators with ultimate influence on multiple targets within or beyond ERK, Sprouty orchestrates a complex, multilayered regulatory system and mediates a crosstalk among different signaling pathways for a coordinated cellular response. As such, Sprouty has been implicated in various developmental and physiological processes. Evidence shows that ERK is aberrantly activated in malignant conditions. Accordingly, Sprouty deregulation has been reported in different cancer types and shown to impact cancer development, progression, and metastasis. In this article, we have tried to provide an overview of the current knowledge about the Sprouty physiology and its regulatory functions in health, as well as an updated review of the Sprouty status in cancer. Putative implications of Sprouty in cancer biology, their clinical relevance, and their proposed applications are also revisited. As a developing story, however, role of Sprouty in cancer remains to be further elucidated. Springer US 2014-04-18 2014 /pmc/articles/PMC4113681/ /pubmed/24744103 http://dx.doi.org/10.1007/s10555-014-9497-1 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Non-Thematic Review Masoumi-Moghaddam, Samar Amini, Afshin Morris, David Lawson The developing story of Sprouty and cancer |
title | The developing story of Sprouty and cancer |
title_full | The developing story of Sprouty and cancer |
title_fullStr | The developing story of Sprouty and cancer |
title_full_unstemmed | The developing story of Sprouty and cancer |
title_short | The developing story of Sprouty and cancer |
title_sort | developing story of sprouty and cancer |
topic | Non-Thematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113681/ https://www.ncbi.nlm.nih.gov/pubmed/24744103 http://dx.doi.org/10.1007/s10555-014-9497-1 |
work_keys_str_mv | AT masoumimoghaddamsamar thedevelopingstoryofsproutyandcancer AT aminiafshin thedevelopingstoryofsproutyandcancer AT morrisdavidlawson thedevelopingstoryofsproutyandcancer AT masoumimoghaddamsamar developingstoryofsproutyandcancer AT aminiafshin developingstoryofsproutyandcancer AT morrisdavidlawson developingstoryofsproutyandcancer |